CAXTON CORP Diversified Active

CIK: 0001388551 · Show all filings

Period: Q3 2018 (← Previous) (Next →)

Filing Date: Nov 14, 2018

Total Value ($000): $108,177 (100.0% shares, 0.0% debt)

Holdings (29)

STRONGBRIDGE BIOPHARMA PLC 28.2%
Value ($000) $30,530 Shares 6,294,789 Est. Cost $2.84 Unrealized
MEI PHARMA INC 14.7%
Value ($000) $15,855 Shares 3,678,600 Est. Cost $3.94 Unrealized
SPY SPDR S&P 500 ETF TR 13.8%
Value ($000) $14,908 Shares 51,279 Est. Cost Unrealized
GARRISON CAP INC 8.5%
Value ($000) $9,212 Shares 1,112,517 Est. Cost $8.42 Unrealized
MOLECULAR TEMPLATES INC 8.0%
Value ($000) $8,620 Shares 1,599,241 Est. Cost $6.43 Unrealized
CM FIN INC 7.1%
Value ($000) $7,698 Shares 895,173 Est. Cost $8.35 Unrealized
SCYNEXIS INC 4.8%
Value ($000) $5,190 Shares 4,325,000 Est. Cost $1.30 Unrealized
ALPS ETF TR 4.1%
Value ($000) $4,469 Shares 418,416 Est. Cost $10.10 Unrealized
BRK/B BERKSHIRE HATHAWAY INC DEL 1.8%
Value ($000) $1,994 Shares 9,312 Est. Cost $135.71 Unrealized +51.2%
JBGS JBG SMITH PPTYS 1.4%
Value ($000) $1,516 Shares 41,170 Est. Cost $34.27 Unrealized
PCG PG&E CORP 1.0%
Value ($000) $1,035 Shares 22,500 Est. Cost $41.94 Unrealized +5.0%
UHAL AMERCO 0.9%
Value ($000) $963 Shares 2,700 Est. Cost $35.55 Unrealized +3.8%
TAPIMMUNE INC 0.7%
Value ($000) $738 Shares 81,540 Est. Cost $9.42 Unrealized
KURA KURA ONCOLOGY INC 0.6%
Value ($000) $607 Shares 34,708 Est. Cost $18.11 Unrealized +5.8%
ACRS ACLARIS THERAPEUTICS INC 0.5%
Value ($000) $577 Shares 39,755 Est. Cost $20.72 Unrealized -17.3%
ARQULE INC 0.5%
Value ($000) $511 Shares 90,254 Est. Cost $5.65 Unrealized
KALA PHARMACEUTICALS INC 0.5%
Value ($000) $506 Shares 51,259 Est. Cost $9.87 Unrealized
CTI BIOPHARMA CORP 0.4%
Value ($000) $427 Shares 197,459 Est. Cost $2.16 Unrealized
INTEC PHARMA LTD JERUSALEM 0.3%
Value ($000) $364 Shares 64,396 Est. Cost $8.94 Unrealized
ALCENTRA CAP CORP 0.3%
Value ($000) $345 Shares 57,677 Est. Cost $8.20 Unrealized
EIGER BIOPHARMACEUTICALS INC 0.3%
Value ($000) $306 Shares 25,494 Est. Cost $12.00 Unrealized
CPRX CATALYST PHARMACEUTICALS INC 0.3%
Value ($000) $276 Shares 72,967 Est. Cost $3.21 Unrealized -2.5%
SPRING BK PHARMACEUTICALS IN 0.2%
Value ($000) $253 Shares 20,986 Est. Cost $12.06 Unrealized
FAR PT ACQUISITION CORP 0.2%
Value ($000) $237 Shares 23,030 Est. Cost $10.18 Unrealized
DICERNA PHARMACEUTICALS INC 0.2%
Value ($000) $225 Shares 14,724 Est. Cost $15.28 Unrealized
SUNESIS PHARMACEUTICALS INC 0.2%
Value ($000) $222 Shares 111,217 Est. Cost $2.05 Unrealized
MARINUS PHARMACEUTICALS INC 0.2%
Value ($000) $202 Shares 20,180 Est. Cost $7.04 Unrealized
CACC CREDIT ACCEP CORP MICH 0.2%
Value ($000) $201 Shares 459 Est. Cost $419.51 Unrealized 0.0%
SIERRA ONCOLOGY INC 0.2%
Value ($000) $190 Shares 111,898 Est. Cost $1.81 Unrealized